Related Experiment Video

Updated: Jun 11, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.6K

An Evolving Landscape: New Therapies for Metastatic Colorectal Cancer

Christiana Mo1, Bhawneet Chadha1, Chaoyuan Kuang2

  • 1Department of Oncology, Montefiore Einstein, Bronx, NY; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY.

Clinical Colorectal Cancer
|September 27, 2024
PubMed

Insights

Novel targeted agents and immunotherapies show promise for advanced colorectal cancer. Research is exploring optimal combinations, especially for microsatellite stable disease, to improve patient outcomes and survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Colorectal cancer treatment is advancing with new targeted agents and immunotherapies.
  • Molecular markers and tumor profiling drive the development of these novel therapies.
  • Current treatments have improved survival, but optimizing combinations is crucial.

Purpose of the Study:

  • To review recent clinical trial data on targeted therapies and immunotherapies for advanced colorectal cancer.
  • To explore the efficacy of combining or sequencing different treatment modalities.
  • To investigate potential therapeutic strategies for microsatellite stable colorectal cancer.

Main Methods:

  • Review of recent clinical trial data.
  • Analysis of outcomes for targeted agents and immunotherapies.
  • Exploration of combination and sequencing strategies.

Main Results:

  • Novel targeted agents and immunotherapies have demonstrated improved progression-free and overall survival in some colorectal cancer patients.
  • Emerging data suggests combination therapies may enhance efficacy, particularly for microsatellite stable colorectal cancer.
  • Optimal sequencing and combination strategies are under active investigation.

Conclusions:

  • Significant progress in targeted therapy and immunotherapy offers new hope for advanced colorectal cancer.
  • Further research is needed to determine the best combination and sequencing approaches for maximal patient benefit.
  • Improving outcomes for microsatellite stable colorectal cancer remains a critical area for therapeutic development.
Keywords:
ChemotherapyClinical trialsColorectal cancerImmunotherapyTargeted therapy

More Related Videos

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis04:22

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

366
Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer06:19

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Published on: July 18, 2017

10.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K